IL5RA and eosinophilic esophagitis: Although studies of IL-5/IL-5R-targeted therapies have been disappointing, whether this is due to greater involvement of other cell types in disease pathogenesis (e.g., mast cells) or the challenges of measuring efficacy in EoE clinical trials remains to be determined [100].